| 1 | Patients | 3.85% | |
| 2 | ASCO | 3.85% | |
| 3 | Status | 2.88% | |
| 4 | mCRPC | 1.92% | |
| 5 | Immune | 1.92% | |
| 6 | Protein | 1.92% | |
| 7 | Checkpoint | 1.92% | |
| 8 | Versus | 1.92% | |
| 9 | Tumor | 1.92% | |
| 10 | Septic | 0.96% | |
| 11 | Prostatitis | 0.96% | |
| 12 | Tissue | 0.96% | |
| 13 | Clinical | 0.96% | |
| 14 | Caused | 0.96% | |
| 15 | Strategies | 0.96% | |
| 16 | Additive | 0.96% | |
| 17 | Risk | 0.96% | |
| 18 | Burden | 0.96% | |
| 19 | Biomarkers | 0.96% | |
| 20 | Study | 0.96% | |
| 21 | Durvalumab | 0.96% | |
| 22 | Spacer | 0.96% | |
| 23 | Inhibitor | 0.96% | |
| 24 | Endosteal | 0.96% | |
| 25 | UT | 0.96% | |
| 26 | Somatic | 0.96% | |
| 27 | Effectiveness | 0.96% | |
| 28 | DME | 0.96% | |
| 29 | Sugar | 0.96% | |
| 30 | Carcinoma | 0.96% | |
| 31 | Placement | 0.96% | |
| 32 | Microsatellite | 0.96% | |
| 33 | Utility | 0.96% | |
| 34 | Outcomes | 0.96% | |
| 35 | Choice | 0.96% | |
| 36 | Mutation | 0.96% | |
| 37 | Perioperative | 0.96% | |
| 38 | Eat | 0.96% | |
| 39 | San | 0.96% | |
| 40 | Hyperostosis | 0.96% | |
| 41 | Better | 0.96% | |
| 42 | School | 0.96% | |
| 43 | Rucaparib | 0.96% | |
| 44 | Health | 0.96% | |
| 45 | Virus | 0.96% | |
| 46 | Who | 0.96% | |
| 47 | Metastatic | 0.96% | |
| 48 | (LRP5) | 0.96% | |
| 49 | Cold | 0.96% | |
| 50 | Antonio | 0.96% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||